FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

31273011000036109: gadoversetamide (AU substance)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
176017011000036115 gadoversetamide en Synonym Active Case sensitive Australian Medicines Terminology module
176018011000036119 gadoversetamide (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
gadoversetamide Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Optimark 6.62 g/20 mL injection, 20 mL syringe has intended active ingredient True gadoversetamide Inferred relationship Some 1316110622
gadoversetamide has intended active ingredient True gadoversetamide Inferred relationship Some 1
gadoversetamide 9.93 g/30 mL injection, syringe has intended active ingredient True gadoversetamide Inferred relationship Some 1334781540
gadoversetamide 9.93 g/30 mL injection, syringe has Australian BoSS True gadoversetamide Inferred relationship Some 1334781540
gadoversetamide 3.31 g/10 mL injection, vial has intended active ingredient True gadoversetamide Inferred relationship Some 1200050154
gadoversetamide 3.31 g/10 mL injection, vial has Australian BoSS True gadoversetamide Inferred relationship Some 1200050154
gadoversetamide 1.65 g/5 mL injection, vial has intended active ingredient True gadoversetamide Inferred relationship Some 193408096
gadoversetamide 1.65 g/5 mL injection, vial has Australian BoSS True gadoversetamide Inferred relationship Some 193408096
gadoversetamide 4.96 g/15 mL injection, syringe has intended active ingredient True gadoversetamide Inferred relationship Some 1698789142
gadoversetamide 4.96 g/15 mL injection, syringe has Australian BoSS True gadoversetamide Inferred relationship Some 1698789142
gadoversetamide 6.62 g/20 mL injection, syringe has intended active ingredient True gadoversetamide Inferred relationship Some 977963428
gadoversetamide 6.62 g/20 mL injection, syringe has Australian BoSS True gadoversetamide Inferred relationship Some 977963428
gadoversetamide 3.31 g/10 mL injection, syringe has intended active ingredient True gadoversetamide Inferred relationship Some 963828396
gadoversetamide 3.31 g/10 mL injection, syringe has Australian BoSS True gadoversetamide Inferred relationship Some 963828396
gadoversetamide 4.96 g/15 mL injection, vial has intended active ingredient True gadoversetamide Inferred relationship Some 1935010900
gadoversetamide 4.96 g/15 mL injection, vial has Australian BoSS True gadoversetamide Inferred relationship Some 1935010900
gadoversetamide 6.62 g/20 mL injection, vial has intended active ingredient True gadoversetamide Inferred relationship Some 775104658
gadoversetamide 6.62 g/20 mL injection, vial has Australian BoSS True gadoversetamide Inferred relationship Some 775104658
Optimark 4.96 g/15 mL injection, 15 mL vial has Australian BoSS True gadoversetamide Inferred relationship Some 742298708
Optimark 9.93 g/30 mL injection, 30 mL syringe has intended active ingredient True gadoversetamide Inferred relationship Some 520211982
Optimark 4.96 g/15 mL injection, 15 mL syringe has Australian BoSS True gadoversetamide Inferred relationship Some 2055172190
Optimark (gadoversetamide 3.31 g / 10 mL) injection, 10 mL syringe (trade product unit of use) has intended active ingredient True gadoversetamide Inferred relationship Some 59111774
Optimark 1.65 g/5 mL injection, 5 mL vial has intended active ingredient True gadoversetamide Inferred relationship Some 1100794468
Optimark 6.62 g/20 mL injection, 20 mL vial has intended active ingredient True gadoversetamide Inferred relationship Some 1079888864
Optimark 3.31 g/10 mL injection, 10 mL vial has intended active ingredient True gadoversetamide Inferred relationship Some 843667106
Optimark 9.93 g/30 mL injection, 30 mL syringe has Australian BoSS True gadoversetamide Inferred relationship Some 520211982
Optimark 4.96 g/15 mL injection, 15 mL syringe has intended active ingredient True gadoversetamide Inferred relationship Some 2055172190
Optimark 4.96 g/15 mL injection, 15 mL vial has intended active ingredient True gadoversetamide Inferred relationship Some 742298708
Optimark 1.65 g/5 mL injection, 5 mL vial has Australian BoSS True gadoversetamide Inferred relationship Some 1100794468
Optimark 6.62 g/20 mL injection, 20 mL syringe has Australian BoSS True gadoversetamide Inferred relationship Some 1316110622
Optimark 6.62 g/20 mL injection, 20 mL vial has Australian BoSS True gadoversetamide Inferred relationship Some 1079888864
Optimark (gadoversetamide 3.31 g / 10 mL) injection, 10 mL syringe (trade product unit of use) has Australian BoSS True gadoversetamide Inferred relationship Some 59111774
Optimark 3.31 g/10 mL injection, 10 mL vial has Australian BoSS True gadoversetamide Inferred relationship Some 843667106

This concept is not in any reference sets

Back to Start